 |
|
|
| |
Lopinavir/ritonavir (LPV/r) Combined with Raltegravir (RAL) Demonstrated Similar Antiviral Efficacy and Safety as LPV/r Combined with Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC) in Treatment-Naïve HIV-1-Infected Subjects: PROGRESS 48 week results
|
| |
| |
Reported by Jules Levin
18th International AIDS Conference, Vienna, Austria, 18-23 July 2010
Jacques Reynes1, Adebayo Lawal2, Federico Pulido3, Ruth Soto-Malave4, Joseph Gathe5, Min Tian2, Linda Fredrick2, Todd Correll2, Thomas Podsadecki2, Angela Nilius2
1. Department of Infectious and Tropical Diseases, Montpellier University Hospital, Montpellier, France 2. Abbott, Abbott Park, Illinois 3. Unidad VIH. Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid Spain 4. University of Puerto Rico, School of Medicine, Infectious Diseases Section, San Juan, Puerto Rico and Innovative Care PSC, Bayamon, Puerto Rico 5. Therapeutic Concepts, Houston, Texas
|
| |
|
|
|
|
|
